Interventions to improve the review of antibiotic therapy in acute care hospitals: a systematic review and narrative synthesis.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
18
05
2020
accepted:
01
07
2020
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
To synthesize current evidence for the effectiveness of interventions to ensure the timely review of antibiotics in acute care hospitals. Five databases were searched from 1 January 2015 to 8 March 2019 for studies in English, focused on the timely review of antibiotics in acute care hospitals. Randomized controlled trials, non-randomized studies, case-control and cohort study designs were eligible. Intervention strategies were categorized according to the Cochrane Effective Practice and Organisation of Care taxonomy of health interventions, then mapped to the intervention functions of the behaviour change wheel. Fourteen studies were included. Most studies (11 out of 14) were conducted in single sites. Nine out of 14 reported intervention delivery by more than one healthcare professional. Physicians were the main targets of interventions in all studies. Thirteen out of 14 studies tested interventions comprising more than one strategy. The three most commonly utilized strategies within interventions were clinical practice guidelines, audit and feedback, and educational materials. Only one study employed theory in intervention evaluation. Reported interventions led to timely review and switch of IV antibiotic therapy, and shortened durations of overall antibiotic therapy. Interventions to improve the review of antibiotics were found to be effective in the short to medium term, with limited evidence of long-term sustainability in multiple sites. Future research may benefit from the application of theory to intervention design and detailed specifications of interventions to aid their easy replication and implementation in different contexts.
Identifiants
pubmed: 34223022
doi: 10.1093/jacamr/dlaa065
pii: dlaa065
pmc: PMC8210161
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
dlaa065Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Références
J Glob Antimicrob Resist. 2020 Mar;20:131-134
pubmed: 31323427
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Ther Adv Drug Saf. 2016 Aug;7(4):165-72
pubmed: 27493720
J Hosp Med. 2018 Jan 25;13(5):336-342
pubmed: 29370318
Implement Sci. 2019 Dec 5;14(1):102
pubmed: 31806037
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Ir J Med Sci. 2017 Aug;186(3):729-732
pubmed: 27686471
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
Int J Surg. 2017 Apr;40:78-82
pubmed: 28232250
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S47-55
pubmed: 26198369
PLoS One. 2019 Jan 16;14(1):e0209847
pubmed: 30650099
Nurs Stand. 2018 Apr 28;33(1):40-44
pubmed: 29583169
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Health Res Policy Syst. 2019 Jan 15;17(1):8
pubmed: 30646911
J Antimicrob Chemother. 2015 Dec;70(12):3384-9
pubmed: 26311841
J Antimicrob Chemother. 2018 Feb 1;73(2):527-530
pubmed: 29077862
BMC Med. 2016 Dec 12;14(1):208
pubmed: 27938372
Antimicrob Resist Infect Control. 2017 Aug 15;6:81
pubmed: 28824799
Biol Pharm Bull. 2016 May 1;39(5):721-7
pubmed: 26923491
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Clin Infect Dis. 2013 Jul;57(2):188-96
pubmed: 23572483
BMC Health Serv Res. 2019 Mar 25;19(1):189
pubmed: 30909897
ACP J Club. 1995 Nov-Dec;123(3):A12-3
pubmed: 7582737
BMC Med Res Methodol. 2018 Jan 18;18(1):12
pubmed: 29347910
Am J Infect Control. 2019 Dec;47(12):1409-1414
pubmed: 31327576
Int J Antimicrob Agents. 2019 May;53(5):606-611
pubmed: 30639630
J Glob Antimicrob Resist. 2014 Mar;2(1):1-6
pubmed: 27873630
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Clin Infect Dis. 2019 Jun 18;69(1):12-20
pubmed: 30445453
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Pharmacol Pharmacother. 2014 Apr;5(2):83-7
pubmed: 24799810
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Biochem Med (Zagreb). 2017 Oct 15;27(3):030201
pubmed: 29180912
J Infus Nurs. 2012 Mar-Apr;35(2):84-91
pubmed: 22382792
Br J Hosp Med (Lond). 2018 Mar 2;79(3):163-167
pubmed: 29528731
Int J Clin Pharm. 2018 Oct;40(5):948-952
pubmed: 30242589
Clin Microbiol Infect. 2015 Feb;21(2):180.e1-7
pubmed: 25658564
Infect Chemother. 2017 Mar;49(1):31-37
pubmed: 28332344
Int J Antimicrob Agents. 2013 Mar;41(3):203-12
pubmed: 23127482
Int J Antimicrob Agents. 2015 Oct;46(4):428-33
pubmed: 26293470
J Antimicrob Chemother. 2018 Jul 1;73(7):1737-1749
pubmed: 29514279
Pharm Pract (Granada). 2018 Apr-Jun;16(2):855
pubmed: 30023021
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Antimicrob Resist Infect Control. 2019 Oct 22;8:162
pubmed: 31649819
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Lancet Infect Dis. 2010 Mar;10(3):167-75
pubmed: 20185095
J Antimicrob Chemother. 2016 Aug;71(8):2295-9
pubmed: 27121400
J Antimicrob Chemother. 2020 May 1;75(5):1338-1346
pubmed: 32016346
J Antimicrob Chemother. 2018 May 1;73(5):1402-1407
pubmed: 29462306
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Clin Microbiol Infect. 2019 May;25(5):538-545
pubmed: 30267927
BMJ Open. 2014 Nov 05;4(11):e006442
pubmed: 25377014
BMJ Open. 2018 Dec 28;8(12):e025101
pubmed: 30593557
Implement Sci. 2016 Oct 19;11(1):141
pubmed: 27756414
BMJ Qual Improv Rep. 2015 Jan 28;4(1):
pubmed: 26734367
Int J Antimicrob Agents. 2015 Feb;45(2):168-73
pubmed: 25511192